Aptinyx competitorsClear all

Aptinyx's top competitors include XBiotech, Kymera Therapeutics, Rubius Therapeutics and Genelux.
Aptinyx
Aptinyx
Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.
XBiotech
XBiotech
XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
Genelux
Genelux
Genelux is a clinical-stage biopharmaceutical company developing a proprietary oncolytic virus-based technology platform.
Founding Date
Founding Date
2015
Founding Date
2005
Founding Date
2017
Founding Date
2013
Founding Date
2001
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Evanston, US HQ
Evanston, US
Locations
Austin, US HQ
Locations
Watertown, US HQ
Locations
Cambridge, US HQ
Smithfield, US
Locations
HQ
Employees
Employees
635% increase
Employees
603% increase
Employees
973% increase
Employees
17423% increase
Employees
10
Valuation ($)
Valuation ($)
207.6 m
Valuation ($)
477.6 m
Valuation ($)
N/A
Valuation ($)
2.2 b
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
270
Twitter followers
2.1 k
Twitter followers
1.3 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
24
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.3
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
373218
Alexa Website Rank
N/A
Alexa Website Rank
264706
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3.5
Employee Rating
2.9
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.6m (FY, 2020)
Revenue (est.)
$44m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($50.1m) (FY, 2020)
Net income
($11.2m) (FY, 2020)
Net income
N/A
Net income
($167.7m) (FY, 2020)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 135m
Total funding raised
N/A
Total funding raised
$ 197m
Total funding raised
$ 245m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

XBiotech
HQ
Austin, US
Employees
60↑ 3% increase

XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.

View company
Kymera Therapeutics
HQ
Watertown, US
Employees
97↑ 3% increase

Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.

View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.

View company
Genelux
HQ
Employees
10

Genelux is a clinical-stage biopharmaceutical company developing a proprietary oncolytic virus-based technology platform.

View company